<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000zi 4500</marc:leader>
    <marc:controlfield tag="001">9.932280</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20240131144420</marc:controlfield>
    <marc:controlfield tag="006">m     o  d f      </marc:controlfield>
    <marc:controlfield tag="007">cr mn|||||||||</marc:controlfield>
    <marc:controlfield tag="008">240110e20180201onca    ob   f000 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
      <marc:subfield code="e">rda</marc:subfield>
      <marc:subfield code="c">CaOODSP</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="045" ind1=" " ind2=" ">
      <marc:subfield code="a">y0y1</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">H14-512/2018E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="0" ind2="0">
      <marc:subfield code="a">Evaluation of the Health Canada Canadian Blood Services contribution programs 2013-14 to 2016-17 : </marc:subfield>
      <marc:subfield code="b">final report / </marc:subfield>
      <marc:subfield code="c">Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="246" ind1="1" ind2="7">
      <marc:subfield code="a">Evaluation of the Health Canada Canadian Blood Services contribution programs 2013-2014 to 2016-2017</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="264" ind1=" " ind2="1">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, </marc:subfield>
      <marc:subfield code="c">February 1, 2018.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">1 online resource (xiii, 55 pages) : </marc:subfield>
      <marc:subfield code="b">colour illustration</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="336" ind1=" " ind2=" ">
      <marc:subfield code="a">text</marc:subfield>
      <marc:subfield code="b">txt</marc:subfield>
      <marc:subfield code="2">rdacontent</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="337" ind1=" " ind2=" ">
      <marc:subfield code="a">computer</marc:subfield>
      <marc:subfield code="b">c</marc:subfield>
      <marc:subfield code="2">rdamedia</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="338" ind1=" " ind2=" ">
      <marc:subfield code="a">online resource</marc:subfield>
      <marc:subfield code="b">cr</marc:subfield>
      <marc:subfield code="2">rdacarrier</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Évaluation des programmes de la Société canadienne du sang bénéficiaires de contributions de Santé Canada 2013-2014 à 2016-2017 : rapport final.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Cover title.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="504" ind1=" " ind2=" ">
      <marc:subfield code="a">Includes bibliographical references (pages 54-55).</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"The purpose of this evaluation was to assess the relevance and performance (effectiveness, efficiency and economy) of the Health Canada Canadian Blood Services (CBS) Contribution Programs, which include the Organ and Tissue Donation and Transplantation (OTDT) Program, and the Blood Research and Development (R&amp;D) Program. The evaluation focused on the period from 2013-14 to 2016-17, and updated findings from the previous evaluation, which covered the period from 2008-09 to 2012-13. The evaluation was undertaken in accordance with the requirements of the Financial Administration Act and the Treasury Board Policy on Results (2016). Through the OTDT Program, Health Canada funds CBS for activities relating to national governance, development of leading clinical practices, system performance improvement, and public education and awareness. Through the Blood R&amp;D Program, Health Canada funds CBS to undertake R&amp;D activities to improve the safety and supply of the Canadian blood system"--Executive summary, page iv.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="610" ind1="2" ind2="0">
      <marc:subfield code="a">Canadian Blood Services</marc:subfield>
      <marc:subfield code="x">Finance</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Donation of organs, tissues, etc.</marc:subfield>
      <marc:subfield code="x">Government policy</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Transplantation of organs, tissues, etc.</marc:subfield>
      <marc:subfield code="x">Government policy</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Blood banks</marc:subfield>
      <marc:subfield code="x">Government policy</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Blood</marc:subfield>
      <marc:subfield code="x">Transfusion</marc:subfield>
      <marc:subfield code="x">Government policy</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Health Canada. </marc:subfield>
      <marc:subfield code="b">Office of Audit and Evaluation, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="2" ind2=" ">
      <marc:subfield code="a">Public Health Agency of Canada. </marc:subfield>
      <marc:subfield code="b">Office of Audit and Evaluation, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Évaluation des programmes de la Société canadienne du sang bénéficiaires de contributions de Santé Canada 2013-2014 à 2016-2017 : </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.933213</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">538 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2024/sc-hc/H14-512-2018-eng.pdf</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2=" ">
      <marc:subfield code="q">HTML</marc:subfield>
      <marc:subfield code="s">N/A</marc:subfield>
      <marc:subfield code="u">https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/evaluation/evaluation-health-canada-canadian-blood-services-contributon-programs-2013-14-2016-17.html</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
